Inge M. Evers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Inge M. Evers has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
A L Aalders
1 shared publicationA M Bos
1 shared publication- Anneloes Kerssen
Department of Perinatology and Gynaecology, University Medical Centre Utrecht, KJ.02.507.0/P.O. Box 85090, 3508 AB Utrecht, The Netherlands
1 shared publication E Van Ballegooie
1 shared publicationG H Visser
1 shared publication- G. H. A. Visser
Afd. Obstetrie en Gynaecologie, Universitair Medisch Centrum, Postbus 85.090, 3508 AB Utrecht
1 shared publication
Latest Publications
- Open Access
- 14 April 2009
- Published by American Diabetes Association in Diabetes Care
- Vol. 32 (7) , 1194-1195
Male Predominance of Congenital Malformations in Infants of Women With Type 1 Diabetes
OBJECTIVE: To investigate sex-related differences in maternal, perinatal, and neonatal outcome in type 1 diabetic pregnancies in the Netherlands. RESEARCH DESIGN AND METHODS: This was a nationwide prospective cohort-based study. Logistic regression analysis was used to identify sex-specific risk factors for adverse pregnancy outcome. RESULTS: A total of 323 type 1 diabetic pregnancies were included; 314 were ongoing after 24 weeks of gestation. There were eight twin pregnancies and one triplet, resulting in 324 infants born after 24 weeks of gestation. Multiple logistic regression analysis showed that the occurrence of congenital malformations was independently associated with male newborns (OR 3.5 [95% CI 1.3–10.0]; P = 0.02). CONCLUSIONS: The higher incidence of congenital malformations in infants of women with type 1 diabetes appears to be restricted to male infants only.
- 14 April 2009
- Published by American Diabetes Association in Diabetes Care
- Vol. 32 (7) , 1194-1195
Open AccessMale Predominance of Congenital Malformations in Infants of Women With Type 1 Diabetes
OBJECTIVE: To investigate sex-related differences in maternal, perinatal, and neonatal outcome in type 1 diabetic pregnancies in the Netherlands. RESEARCH DESIGN AND METHODS: This was a nationwide prospective cohort-based study. Logistic regression analysis was used to identify sex-specific risk factors for adverse pregnancy outcome. RESULTS: A total of 323 type 1 diabetic pregnancies were included; 314 were ongoing after 24 weeks of gestation. There were eight twin pregnancies and one triplet, resulting in 324 infants born after 24 weeks of gestation. Multiple logistic regression analysis showed that the occurrence of congenital malformations was independently associated with male newborns (OR 3.5 [95% CI 1.3–10.0]; P = 0.02). CONCLUSIONS: The higher incidence of congenital malformations in infants of women with type 1 diabetes appears to be restricted to male infants only.
- 1 May 2003
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 13 (5) , 309-313
Poor glucose control in women with type 1 diabetes mellitus and 'safe' hemoglobin A1c values in the first trimester of pregnancy
- 1 May 2003
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 13 (5) , 309-313
Poor glucose control in women with type 1 diabetes mellitus and 'safe' hemoglobin A1c values in the first trimester of pregnancy
- 22 April 2000
- Vol. 144 (17) , 804-9
[Pregnancy in women with diabetes mellitus type I: maternal and perinatal complications, in spite of good blood glucose control].
To examine the maternal and neonatal outcome of pregnancies of women with type I diabetes mellitus. Retrospective. The medical records of pregnancies (> or = 16 weeks) in women with type I diabetes mellitus between 1986/'97 were studied in University Medical Center Utrecht, Academic Hospital Groningen and Isala Clinics, location 'De Weezenlanden', Zwolle, the Netherlands. During the study period, 172 women had 220 pregnancies: 212 single and 8 twin pregnancies. The mean age was 29.1 years (SD: 4.1), the mean duration of standing of the diabetes was 12 years (range: 1-32) and the mean concentration of glycosylated haemoglobin (HbA1c) was 6.3% at 10 weeks of pregnancy. The incidence of children with congenital malformations was 4 times higher (n = 19; 9.0%) than that in the Dutch population (2%). Macrosomia occurred in 92 children (43.4%) and perinatal mortality in 7 (3.3%). Maternal hypertensive complications occurred in 39 single pregnancies (18.4%), which is 2-3 times more often than in the Dutch population. In type I diabetic women maternal complications, perinatal morbidity and mortality are increased, despite near optimal glycaemic control.
- 22 April 2000
- Vol. 144 (17) , 804-9
[Pregnancy in women with diabetes mellitus type I: maternal and perinatal complications, in spite of good blood glucose control].
To examine the maternal and neonatal outcome of pregnancies of women with type I diabetes mellitus. Retrospective. The medical records of pregnancies (> or = 16 weeks) in women with type I diabetes mellitus between 1986/'97 were studied in University Medical Center Utrecht, Academic Hospital Groningen and Isala Clinics, location 'De Weezenlanden', Zwolle, the Netherlands. During the study period, 172 women had 220 pregnancies: 212 single and 8 twin pregnancies. The mean age was 29.1 years (SD: 4.1), the mean duration of standing of the diabetes was 12 years (range: 1-32) and the mean concentration of glycosylated haemoglobin (HbA1c) was 6.3% at 10 weeks of pregnancy. The incidence of children with congenital malformations was 4 times higher (n = 19; 9.0%) than that in the Dutch population (2%). Macrosomia occurred in 92 children (43.4%) and perinatal mortality in 7 (3.3%). Maternal hypertensive complications occurred in 39 single pregnancies (18.4%), which is 2-3 times more often than in the Dutch population. In type I diabetic women maternal complications, perinatal morbidity and mortality are increased, despite near optimal glycaemic control.